-
1
-
-
84887437641
-
Publication of trials funded by the National Heart, Lung, and Blood Institute
-
24224625
-
Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2013;369:1926-1934. doi: 10. 1056/NEJMsa1300237 PMID: 24224625
-
(2013)
N Engl J Med.
, vol.369
, pp. 1926-1934
-
-
Gordon, D.1
Taddei-Peters, W.2
Mascette, A.3
Antman, M.4
Kaufmann, P.G.5
Lauer, M.S.6
-
3
-
-
84887437641
-
Publication of trials funded by the National Heart, Lung, and Blood Institute
-
Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2013;369:1226-1234.
-
(2013)
N Engl J Med.
, vol.369
, pp. 1226-1234
-
-
Gordon, D.1
Taddei-Peters, W.2
Mascette, A.3
Antman, M.4
Kaufmann, P.G.5
Lauer, M.S.6
-
4
-
-
84906094329
-
Tracking the pharmaceutical pipeline: Clinical trials and global disease burden
-
24816032
-
Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci 2014;7:297-299. doi: 10.1111/cts.12163 PMID: 24816032
-
(2014)
Clin Transl Sci
, vol.7
, pp. 297-299
-
-
Cottingham, M.D.1
Kalbaugh, C.A.2
Fisher, J.A.3
-
5
-
-
84925347795
-
Peering into the pharmaceutical "pipeline": Investigational drugs, clinical trials, and industry priorities
-
25159693 Apr.
-
Fisher JA, Cottingham MD, Kalbaugh CA. Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities. Soc Sci Med. 2015 Apr; 131:322-330. doi: 10.1016/j. socscimed.2014.08.023 PMID: 25159693
-
(2015)
Soc Sci Med.
, vol.131
, pp. 322-330
-
-
Fisher, J.A.1
Cottingham, M.D.2
Kalbaugh, C.A.3
-
6
-
-
84928036813
-
Cardiovascular drug development: Is it dead or just hibernating?
-
25881939
-
Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, et al. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol. 2015;65:1567-1582. doi: 10.1016/j.jacc.2015.03.016 PMID: 25881939
-
(2015)
J Am Coll Cardiol.
, vol.65
, pp. 1567-1582
-
-
Fordyce, C.B.1
Roe, M.T.2
Ahmad, T.3
Libby, P.4
Borer, J.S.5
Hiatt, W.R.6
-
7
-
-
84903947419
-
Alzheimer's disease drug-development pipeline: Few candidates, frequent failures
-
25024750
-
Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 2014;6:37. doi: 10.1186/alzrt269 PMID: 25024750
-
(2014)
Alzheimers Res Ther
, vol.6
, pp. 37
-
-
Cummings, J.L.1
Morstorf, T.2
Zhong, K.3
-
9
-
-
40449088049
-
Moving toward transparency of clinical trials
-
18323436
-
Zarin DA, Tse T. Medicine. Moving toward transparency of clinical trials. Science 2008;319:1340-1342. doi: 10.1126/science.1153632 PMID: 18323436
-
(2008)
Science
, vol.319
, pp. 1340-1342
-
-
Zarin, D.A.1
Medicine, T.T.2
-
10
-
-
29544449337
-
Trial registration at ClinicalTrials.gov between May and October 2005
-
16382064
-
Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;; 353:2779-2787. PMID: 16382064
-
(2005)
N Engl J Med.
, vol.353
, pp. 2779-2787
-
-
Zarin, D.A.1
Tse, T.2
Ide, N.C.3
-
11
-
-
79952267051
-
The ClinicalTrials.gov results database-update and key issues
-
21366476
-
Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med. 2011;364:852-860. doi: 10.1056/NEJMsa1012065 PMID: 21366476
-
(2011)
N Engl J Med.
, vol.364
, pp. 852-860
-
-
Zarin, D.A.1
Tse, T.2
Williams, R.J.3
Califf, R.M.4
Ide, N.C.5
-
12
-
-
0035906308
-
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
-
11308435
-
Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-1991. PMID: 11308435
-
(2001)
JAMA
, vol.285
, pp. 1987-1991
-
-
Moher, D.1
Schulz, K.F.2
Altman, D.3
-
13
-
-
84900455772
-
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: A modeling study
-
24798522
-
Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, et al. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med 2014;160:594-602. doi: 10.7326/M13-2348 PMID: 24798522
-
(2014)
Ann Intern Med
, vol.160
, pp. 594-602
-
-
Roth, J.A.1
Etzioni, R.2
Waters, T.M.3
Pettinger, M.4
Rossouw, J.E.5
Anderson, G.L.6
|